Business Context and Reporting Period
Creative Medical Technology Holdings, Inc., a Nevada corporation, filed this Form 8-K on July 6, 2018. The company is headquartered in Phoenix, Arizona, and is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding a specific corporate event and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material event reported is the initiation of a program aimed at treating cancer-associated wasting (cachexia). On July 6, 2018, the Company announced the in-licensing of patent application #15/814284, entitled "Treatment of Cachexia Using Stem Cells and Products Thereof."
Guidance, Outlook, and Risks
- Forward-Looking Statements: The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of the date of the report.
- Risks and Contingencies: Actual results may differ materially from anticipated results due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2017, and subsequent filings.
- Management Commentary: The Company assumes no duty or obligation to update or revise forward-looking statements, though it may do so as warranted or required by law.
Investor Verification Checklist
- Verify the status and validity of patent application #15/814284 regarding the treatment of cachexia.
- Review the terms of the in-licensing agreement for the patent application.
- Examine the Company's most recent Form 10-K (year ended December 31, 2017) for detailed risk factors and financial health.
- Confirm the Company's current cash position and ability to fund the new program, as this 8-K does not provide liquidity data.